What Matters Now
CME
Real-World Decisions in R/R B-Cell Lymphoma
Joshua Brody, M.D., Mount Sinai
Manik Uppal, M.D., Mount Sinai
86% of Peers Changed Their Practice After this Clinical Scenario
CME
Balancing effective bispecific therapy delivery against logistical constraints and patient comorbidities in a resource-limited setting.
What Matters Now
CME
Real-World Decisions in R/R B-Cell Lymphoma
Joshua Brody, M.D., Mount Sinai
Manik Uppal, M.D., Mount Sinai
Corresponding Scenario
Bispecific Candidacy in an Older FL Patient: Is Treatment Feasible?
See experiences from 199 peers
Balancing effective bispecific therapy delivery against logistical constraints and patient comorbidities in a resource-limited setting.
How clinicians responded after this Clinical Scenario
67
%
begin unsure how to apply evidence
86
%
will implement a practice change
